PsoBest – Das Deutsche Psoriasis-Register: Ein Abbild der Versorgung

Zusammenfassung

PsoBest ist heute das größte Patientenregister in der deutschen Dermatologie. Im Auftrag der Deutschen Dermatologischen Gesellschaft und des Berufsverbandes der Deutschen Dermatologen dokumentiert das Competenzentrum Versorgungsforschung in der Dermatologie gemeinsam mit den teilnehmenden Dermatologen und ihren Patienten die Versorgung der mittelschweren und schweren Psoriasis und Psoriasis-Arthritis in Deutschland. Im Rahmen des Europäischen Netzwerks der Psoriasis-Register trägt PsoBest proaktiv zu einem internationalen Frühwarn- und Überwachungssystem der Arzneimittelsicherheit bei. Ziel des Registers ist die Gewinnung eines umfassenden Abbilds der Versorgung. Dank der großen und weiterhin steigenden Anzahl aktiv teilnehmender Dermatologen und Patienten aus ganz Deutschland sowie einer eingespielten Zusammenarbeit und Kommunikation auf allen Studienebenen wird dieses Abbild immer schärfer.

Abstract

PsoBest is the largest patient registry in German dermatology to date. Real world routine care in moderate and severe psoriasis and psoriatic arthritis in Germany is observed in cooperation of dermatologists, patients and the German Center for Health Services Research in Dermatology on behalf of the German Dermatologic Society and the Association of German Dermatologists. As part of the European network of psoriasis registries, PsoBest proactively contributes to an international rapid alert and surveillance system for drug safety. Purpose of the registry is to retrieve a comprehensive image of routine care. Due to the large and continuously growing number of actively participating dermatologists and patients from all over Germany, as well as the well-rehearsed cooperation and communication between all levels of the registry, the image is getting shaper.

• Literatur

• 1 Augustin M, Spehr C, Radtke MA et al. German Psoriasis Registry PsoBest: Objectives, methodology and first baseline data. J Dtsch Dermatol Ges 2014; 12: 48-57
• 2 Radtke MA, Rustenbach SJ, Reusch M et al. Influenza vaccination rate among patients with moderate to severe psoriasis. J Dtsch Dermatol Ges 2013; 11: 837-844
• 3 Zink A, Listing J, Klindworth C et al. The national database of the German Collaborative Arthritis Centres: I. Structure, aims, and patients. Ann Rheum Dis 2001; 60: 199-206
• 4 Müller D, Augustin M, Banik N et al. Memorandum Register für die Versorgungsforschung. Gesundheitswesen 2010; 72: 824-839
• 5 Glicklich R, Dreyer N. Registries for Evaluating Patient Outcomes: A User’s Guide. 2nd. ed. Rockville (MD): Agency for Healthcare Research and Quality (US); 2010
• 6 The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP). Guide on Methodological Standards in Pharmacoepidemiology. EMA/95098/2010. http://www.encepp.eu/standards_and_guidances letzter Zugriff: 27. 3. 2015
• 7 Schmitt-Egenolf M. Psoriasis therapy in real life: the need for registries. Dermatology 2006; 213: 327-330
• 8 Lecluse LL, Naldi L, Stern RS et al. National registries of systemic treatment for psoriasis and the European ‘Psonet’ initiative. Dermatology 2009; 218: 347-356
• 9 Agency EM. The Rules Governing Medicinal Products in the European Union – Guidelines on Pharmacovigilance for Medicinal Products for Human Use. 2008. Vol. 9a. http://ec.europa.eu/health/files/pharmacos/docs/doc2005/12-05/draft_of_volume_9a_12_2005_en.pdf letzter Zugriff: 27. 3. 2015
• 10 U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes 2006; 4: 79
• 11 Agency EM. Note for Guidance on Clinical Safety Data Management. 2009. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002749.pdf letzter Zugriff: 27. 3. 2015
• 12 Medical Dictionary for Regulatory Activities terminology is the international medical terminology developed under the auspices of the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). http://www.meddra.msso.com letzter Zugriff: 27. 3. 2015
• 13 (ISPE) ISoP. Guidelines for good pharmacoepidemiology practices (GPP). Pharmacoepidemiol Drug Saf 2008; 17: 200-208
• 14 Leitlinien und Empfehlungen zur Sicherung von Guter Epidemiologischer Praxis (GEP). http://www.gesundheitsforschungbmbf.de/_media/Empfehlungen_GEP.pdf letzter Zugriff: 27. 3. 2015
• 15 Elm Evon, Altman DG, Egger M et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 2007; 335: 806-880
• 16 Guideline on good pharmacovigilance practices (GVP) Module VIII – Post-authorisation safety studies. European Medicines Agency and Heads of Medicines Agencies; 2012
• 17 Ormerod AD, Augustin M, Baker C et al. Challenges for synthesising data in a network of registries for systemic psoriasis therapies. Dermatology 2012; 224: 236-243
• 18 Garcia-Doval I, Rustenbach SJ, Stern R et al. Psonet Network. Systemic psoriasis therapy shows high between-country variation: a sign of unwarranted variation? Cross-sectional analysis of baseline data from the PSONET registries. Br J Dermatol 2013; 169: 710-714